Myra E. van Linde

1.2k total citations
34 papers, 719 citations indexed

About

Myra E. van Linde is a scholar working on Genetics, Oncology and Molecular Biology. According to data from OpenAlex, Myra E. van Linde has authored 34 papers receiving a total of 719 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Genetics, 14 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Myra E. van Linde's work include Glioma Diagnosis and Treatment (18 papers), Cancer survivorship and care (7 papers) and Brain Metastases and Treatment (6 papers). Myra E. van Linde is often cited by papers focused on Glioma Diagnosis and Treatment (18 papers), Cancer survivorship and care (7 papers) and Brain Metastases and Treatment (6 papers). Myra E. van Linde collaborates with scholars based in Netherlands, United States and Australia. Myra E. van Linde's co-authors include Wouter R. van Furth, D. J. Richel, Lukas J.A. Stalpers, Joost J.C. Verhoeff, Henk M.W. Verheul, Jaap C. Reijneveld, Olaf van Tellingen, William P. J. Leenders, An Claes and Annemiek Walenkamp and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Myra E. van Linde

31 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Myra E. van Linde Netherlands 14 365 219 188 157 154 34 719
Luisa Bellu Italy 13 465 1.3× 162 0.7× 128 0.7× 218 1.4× 158 1.0× 43 690
Ardi Pambuku Italy 11 451 1.2× 174 0.8× 130 0.7× 167 1.1× 190 1.2× 27 648
Ugonma Chukwueke United States 14 370 1.0× 228 1.0× 174 0.9× 266 1.7× 122 0.8× 48 798
Eva María Corrales-García Spain 7 375 1.0× 270 1.2× 88 0.5× 118 0.8× 215 1.4× 12 754
Marta Peñas-Prado United States 16 627 1.7× 231 1.1× 141 0.8× 264 1.7× 174 1.1× 68 861
M. Lahutte France 10 483 1.3× 339 1.5× 149 0.8× 224 1.4× 196 1.3× 28 1.0k
Armin Muigg Austria 11 315 0.9× 220 1.0× 205 1.1× 171 1.1× 92 0.6× 23 883
Terri Chew United States 5 358 1.0× 203 0.9× 149 0.8× 189 1.2× 146 0.9× 5 857
Sadhana Jackson United States 15 220 0.6× 311 1.4× 198 1.1× 145 0.9× 151 1.0× 34 803
Ichiyo Shibahara Japan 19 576 1.6× 255 1.2× 195 1.0× 187 1.2× 181 1.2× 73 1.0k

Countries citing papers authored by Myra E. van Linde

Since Specialization
Citations

This map shows the geographic impact of Myra E. van Linde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Myra E. van Linde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Myra E. van Linde more than expected).

Fields of papers citing papers by Myra E. van Linde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Myra E. van Linde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Myra E. van Linde. The network helps show where Myra E. van Linde may publish in the future.

Co-authorship network of co-authors of Myra E. van Linde

This figure shows the co-authorship network connecting the top 25 collaborators of Myra E. van Linde. A scholar is included among the top collaborators of Myra E. van Linde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Myra E. van Linde. Myra E. van Linde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamers, Femke, Myra E. van Linde, Annemarie Braamse, et al.. (2024). Network analysis used to investigate the interplay among somatic and psychological symptoms in patients with cancer and cancer survivors: a scoping review. Journal of Cancer Survivorship. 19(4). 1198–1211. 5 indexed citations
2.
Driessen, C.M.L., Janine Nuver, Mariëtte Labots, et al.. (2024). The STELLAR trial: a phase II/III randomized trial of high-dose, intermittent sunitinib in patients with recurrent glioblastoma. Brain Communications. 6(4). fcae241–fcae241. 4 indexed citations
3.
Röttgering, J G, Mathilde C.M. Kouwenhoven, Tjeerd J. Postma, et al.. (2023). Frequency and burden of potentially treatable symptoms in glioma patients with stable disease. Heliyon. 9(2). e13278–e13278. 1 indexed citations
4.
Driessen, C.M.L., Janine Nuver, Mariëtte Labots, et al.. (2023). Abstract CT139: The STELLAR trial: A phase II/III study of high-dose intermittent sunitinib in patients with recurrent glioblastoma. Cancer Research. 83(8_Supplement). CT139–CT139. 1 indexed citations
5.
Röttgering, J G, Linda Douw, Martin Klein, et al.. (2022). Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis. Cannabis and Cannabinoid Research. 8(1). 41–55. 5 indexed citations
6.
Holtmaat, Karen, Birgit I. Lissenberg‐Witte, Simone E. J. Eerenstein, et al.. (2022). Efficacy of the eHealth application Oncokompas, facilitating incurably ill cancer patients to self-manage their palliative care needs: A randomized controlled trial. The Lancet Regional Health - Europe. 18. 100390–100390. 17 indexed citations
7.
Broekman, Marike L. D., Filip De Vos, Edwin Cuppen, et al.. (2022). Study protocol of the GLOW study: maximising treatment options for recurrent glioblastoma patients by whole genome sequencing-based diagnostics—a prospective multicenter cohort study. BMC Medical Genomics. 15(1). 233–233. 5 indexed citations
8.
Numan, Tianne, Bastiaan Moraal, Jaap C. Reijneveld, et al.. (2021). Non-invasively measured brain activity and radiological progression in diffuse glioma. Scientific Reports. 11(1). 18990–18990. 14 indexed citations
9.
Lamers, Femke, Myra E. van Linde, Joyce M. van Dodewaard-de Jong, et al.. (2021). Clinical judgment of the need for professional mental health care in patients with cancer: a qualitative study among oncologists and nurses. Journal of Cancer Survivorship. 17(3). 884–893. 3 indexed citations
10.
Linde, Myra E. van, Roelien H. Enting, René H.J. Otten, et al.. (2020). The Current Status of Immune Checkpoint Inhibitors in Neuro-Oncology: A Systematic Review. Cancers. 12(3). 586–586. 43 indexed citations
11.
Linde, Myra E. van, Tonny Lagerweij, Henk M.W. Verheul, et al.. (2020). Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma. Neuro-Oncology Advances. 2(1). vdaa151–vdaa151. 4 indexed citations
12.
Dekker, Joost, Annemarie Braamse, Hilde M. Buiting, et al.. (2020). Clinical management of emotions in patients with cancer: introducing the approach “emotional support and case finding”. Translational Behavioral Medicine. 10(6). 1399–1405. 22 indexed citations
13.
Vorst, Maurice J. D. L. van der, Myra E. van Linde, Theo van Voorthuizen, et al.. (2020). Metoclopramide, Dexamethasone, or Palonosetron for Prevention of Delayed Chemotherapy-Induced Nausea and Vomiting After Moderately Emetogenic Chemotherapy (MEDEA): A Randomized, Phase III, Noninferiority Trial. The Oncologist. 26(1). e173–e181. 11 indexed citations
14.
Linde, Myra E. van, Annemarie Braamse, Emma H. Collette, et al.. (2020). Clinical assessment of emotions in patients with cancer: Diagnostic accuracy compared with two reference standards. Psycho-Oncology. 29(4). 775–780. 5 indexed citations
15.
16.
Molenaar, Remco J., Robert J.S. Coelen, Mohammed Khurshed, et al.. (2017). Study protocol of a phase IB/II clinical trial of metformin and chloroquine in patients with IDH1 -mutated or IDH2 -mutated solid tumours. BMJ Open. 7(6). e014961–e014961. 71 indexed citations
17.
Linde, Myra E. van, Philip C. De Witt Hamer, Jaap C. Reijneveld, et al.. (2017). Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis. Journal of Neuro-Oncology. 135(1). 183–192. 143 indexed citations
18.
Linde, Myra E. van, Johannes C. van der Mijn, Thang V. Pham, et al.. (2016). Evaluation of potential circulating biomarkers for prediction of response to chemoradiation in patients with glioblastoma. Journal of Neuro-Oncology. 129(2). 221–230. 14 indexed citations
19.
20.
Verhoeff, Joost J.C., Olaf van Tellingen, An Claes, et al.. (2009). Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme. BMC Cancer. 9(1). 444–444. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luisa Bellu Breakdown of academic impact, for papers by Ardi Pambuku Breakdown of academic impact, for papers by Ugonma Chukwueke Breakdown of academic impact, for papers by Eva María Corrales-García Breakdown of academic impact, for papers by Marta Peñas-Prado Breakdown of academic impact, for papers by M. Lahutte Breakdown of academic impact, for papers by Armin Muigg Breakdown of academic impact, for papers by Terri Chew Breakdown of academic impact, for papers by Sadhana Jackson Breakdown of academic impact, for papers by Ichiyo Shibahara
Rankless by CCL
2026